{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:48:27Z","timestamp":1790704107119,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jaut.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,7,27]],"date-time":"2015-07-27T12:49:50Z","timestamp":1438001390000},"page":"68-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus"],"prefix":"10.1016","volume":"63","author":[{"given":"Anna-Helena","family":"Saariaho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arja","family":"Vuorela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias L.","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Partinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"Vaarala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2015.07.006_bib1","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.07.006_bib2","unstructured":"L\u00e4kemedelsverket. A Swedish Registry Based Cohort Study Provides Strengthened Evidence of an Association between Vaccination with Pandemrix and narcolepsy in children and adolescents. Available from: https:\/\/lakemedelsverket.se\/english\/All-news\/NYHETER-2011\/A-Swedish-registry-based-cohort-study-provides-strengthened-evidence-of-an-association-between-vaccination-with-Pandemrix-and-narcolepsy-in-children-and-adolescents-\/. (accessed 07.07.15)."},{"key":"10.1016\/j.jaut.2015.07.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.07.006_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1473-3099(13)70238-X","article-title":"Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action","volume":"14","author":"Barker","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jaut.2015.07.006_bib5","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jaut.2015.07.006_bib6","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","article-title":"Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France","volume":"136","author":"Dauvilliers","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2015.07.006_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","author":"Heier","year":"2013","journal-title":"Sleep. Med."},{"key":"10.1016\/j.jaut.2015.07.006_bib8","first-page":"20789","article-title":"Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010","volume":"19","author":"Flanagan","year":"2014","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jaut.2015.07.006_bib9","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.07.006_bib10","doi-asserted-by":"crossref","first-page":"e114361","DOI":"10.1371\/journal.pone.0114361","article-title":"Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk","volume":"9","author":"Vaarala","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.07.006_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbi.2014.11.004","article-title":"Comparison of pandemrix and arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development","volume":"47","author":"Jacob","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jaut.2015.07.006_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab2354","article-title":"Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2","volume":"7","author":"Ahmed","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2015.07.006_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2015.07.006_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1474-4422(14)70075-4","article-title":"Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination","volume":"13","author":"Partinen","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2015.07.006_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jaut.2015.07.006_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2015.07.006_bib17","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2015.07.006_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11910-010-0101-y","article-title":"Hypocretins in the control of sleep and wakefulness","volume":"10","author":"Bonnavion","year":"2010","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jaut.2015.07.006_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2013.02.003","article-title":"Genetic association, seasonal infections and autoimmune basis of narcolepsy","volume":"43","author":"Singh","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.07.006_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2015.07.006_bib21","doi-asserted-by":"crossref","first-page":"e68402","DOI":"10.1371\/journal.pone.0068402","article-title":"No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland","volume":"8","author":"Melen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.07.006_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1172\/JCI41366","article-title":"Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients","volume":"120","author":"Cvetkovic-Lopes","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2015.07.006_bib23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/sleep\/33.7.875","article-title":"Anti-tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy","volume":"33","author":"Toyoda","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2015.07.006_bib24","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/sleep\/33.7.869","article-title":"Anti-tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy","volume":"33","author":"Kawashima","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2015.07.006_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.031","article-title":"A\/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009\u20132010","volume":"50","author":"Lind","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.07.006_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/sleep\/29.5.601","article-title":"The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy","volume":"29","author":"Scammell","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.jaut.2015.07.006_bib27","doi-asserted-by":"crossref","first-page":"E3735","DOI":"10.1073\/pnas.1412189111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","volume":"111","author":"Bergman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2015.07.006_bib28","doi-asserted-by":"crossref","first-page":"e0129555","DOI":"10.1371\/journal.pone.0129555","article-title":"Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination","volume":"10","author":"Thebault","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2015.07.006_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","article-title":"Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice","volume":"45","author":"Katzav","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.07.006_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12016-010-8213-3","article-title":"Guillain-Barre syndrome\u2013a classical autoimmune disease triggered by infection or vaccination","volume":"42","author":"Israeli","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.07.006_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.1996.tb00127.x","article-title":"Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease","volume":"16","author":"Moran","year":"1996","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.jaut.2015.07.006_bib32","first-page":"3","article-title":"Cerebrospinal fluid biomarkers in Guillain-Barre syndrome\u2013where do we stand?","volume":"256","author":"Brettschneider","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.jaut.2015.07.006_bib33","volume":"vol. 2012","author":"Kolter","year":"2012"},{"key":"10.1016\/j.jaut.2015.07.006_bib34","first-page":"3","article-title":"Review: Glycosphingolipids in health and disease","volume":"34","author":"Zhang","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.jaut.2015.07.006_bib35","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s11064-012-0744-y","article-title":"Functional roles of gangliosides in neurodevelopment: an overview of recent advances","volume":"37","author":"Yu","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jaut.2015.07.006_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1086\/589624","article-title":"Anti-ganglioside antibody induction by swine (A\/NJ\/1976\/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barr\u00e9 syndrome","volume":"15","author":"Nachamkin","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2015.07.006_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1750-2659.2011.00294.x","article-title":"No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies","volume":"6","author":"Wang","year":"2012","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.jaut.2015.07.006_bib38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/jnnp.2010.227777","article-title":"Lack of antibody response to Guillain-Barr\u00e9 syndrome-related gangliosides in mice and men after novel flu vaccination","volume":"83","author":"Yuki","year":"2012","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.jaut.2015.07.006_bib39","first-page":"286","article-title":"Association of allergy, asthma and IgE sensitisation to adenoidectomy and infections in children","volume":"45","author":"Suvilehto","year":"2007","journal-title":"Rhinology"},{"key":"10.1016\/j.jaut.2015.07.006_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(03)00085-5","article-title":"Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy","volume":"341","author":"Overeem","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jaut.2015.07.006_bib41","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1212\/WNL.57.11.2029","article-title":"Age at onset of narcolepsy in two large populations of patients in France and Quebec","volume":"57","author":"Dauvilliers","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2015.07.006_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1196\/annals.1398.031","article-title":"A\u00a0new line immunoassay for the multiparametric detection of antiganglioside autoantibodies in patients with autoimmune peripheral neuropathies","volume":"1109","author":"Conrad","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jaut.2015.07.006_bib43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jocn.2013.07.041","article-title":"Anti-glycolipid antibodies in patients with neuropathy: a diagnostic assessment","volume":"21","author":"Johannis","year":"2014","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.jaut.2015.07.006_bib44","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2012.02.009","article-title":"Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus","volume":"30","author":"Lei","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2015.07.006_bib45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0264-410X(99)00219-4","article-title":"Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP)","volume":"18","author":"Estevez","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jaut.2015.07.006_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an Adjuvant System containing alpha-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"Garcon","year":"2012","journal-title":"Expert Rev. Vacc."},{"key":"10.1016\/j.jaut.2015.07.006_bib47","doi-asserted-by":"crossref","first-page":"13675","DOI":"10.1021\/la2027175","article-title":"Effect of the beta-propiolactone treatment on the adsorption and fusion of influenza A\/Brisbane\/59\/2007 and A\/New Caledonia\/20\/1999 virus H1N1 on a dimyristoylphosphatidylcholine\/ganglioside GM3 mixed phospholipids monolayer at the air-water interface","volume":"27","author":"Desbat","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.jaut.2015.07.006_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj1730697","article-title":"Occurrence of glycosphingolipids in chicken egg yolk","volume":"173","author":"Li","year":"1978","journal-title":"Biochem. J."},{"key":"10.1016\/j.jaut.2015.07.006_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02535698","article-title":"Lipid content of swine influenza and other vaccines","volume":"21","author":"Leskawa","year":"1986","journal-title":"Lipids"},{"key":"10.1016\/j.jaut.2015.07.006_bib50","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1194\/jlr.M200010-JLR200","article-title":"Association of GM4 ganglioside with the membrane surrounding lipid droplets in shark liver","volume":"43","author":"Li","year":"2002","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jaut.2015.07.006_bib51","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1096\/fj.05-4911fje","article-title":"Ganglioside GM3 is involved in neuronal cell death","volume":"20","author":"Sohn","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jaut.2015.07.006_bib52","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/glycob\/cwq031","article-title":"Localization and imaging of sialylated glycosphingolipids in brain tissue sections by MALDI mass spectrometry","volume":"20","author":"Colsch","year":"2010","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaut.2015.07.006_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jnr.20228","article-title":"Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells","volume":"78","author":"Kanda","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.jaut.2015.07.006_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2014.08.002","article-title":"Predicting post-vaccination autoimmunity: who might be at risk?","volume":"92","author":"Soriano","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jaut.2015.07.006_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity-\u2018vaccinosis\u2019: a dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.07.006_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/08830181003792795","article-title":"Vaccinations and autoimmune diseases","volume":"29","author":"Salemi","year":"2010","journal-title":"Int. Rev. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115300093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:12:38Z","timestamp":1760256758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841115300093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":56,"alternative-id":["S0896841115300093"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2015.07.006","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}